StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27−0.09 (-25.05%)

Close on Nov 17, 2026Market cap $2.88MP/E –Yield –

Gelteq total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Gelteq's total debt was A$5.11M at Dec 31, 2025. For fiscal 2025 it was A$8.42M, up 50.3% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$8.42M+50.3%
FY2024Jun 30, 2024A$5.60M+126.2%
FY2023Jun 30, 2023A$2.48M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025A$5.11M+106.5%
Q4 FY2025CQ2 2025Jun 30, 2025A$8.42M–
Q2 FY2025CQ4 2024Dec 31, 2024A$3.90M–
Q4 FY2024CQ2 2024Jun 30, 2024A$5.60M–
Q4 FY2023CQ2 2023Jun 30, 2023A$2.48M–

More Gelteq figures

See a number that looks wrong?